Skip to main content
. 2021 Jun 3;9:675194. doi: 10.3389/fbioe.2021.675194

TABLE 3.

Antisense oligonucleotides in IBD treatment.

Antisense oligonucleotides for IBD treatment
Target of AONs Administration approach
Intracellular adhesion molecule-1 (alicaforsen) (Jairath et al., 2017) Intravenous, rectal
Inhibition of Smad7 (mongersen) (Boirivant et al., 2006) Oral
NF-κBp65 (Murano et al., 2000) Intracolonic
Blocking CD154/CD40 interactions (Gao et al., 2005) Intracolonic
TNF-α (Duan et al., 2019) Oral